Amarin Corp Plc (AMRN)

[ratna1]

Dear Jesse, thank you for your kind response! I fully understand where you are coming from. I used to teach and conduct continuing education programs on 3 continents and was well sought after for conferences until I fell really ill due to a massive lead poisoning in 2006 and had to cancel numerous appearences due to serious damage in the peripheral nervous system as well as my opticus not to mention liver, kidney etc.. .
Up to that point I also published at least quarterly. Within a single year invitations to conferences started to dwindle and after 3 years without new publications I was virtually forgotten even so far I had mostly repeat attendees at my seminars...
Anyway I digress:
the arrogance bred into the corporate mental DNA is staggering and I can just see it how they tried to ignore an outsider advising them on something they overlooked even so they got paid for finding it themselves... total NO GO area...
However trial lawyers are a different breed. They don't have to defend their corporate standing, home turf and territory. Usually they are highly incentivized for a positive trial outcome. Which is why they have huge research staffs that might be eager to get tipped off to an inroad they overlooked!
Maybe they would be attentive as well to the red flag of the slides of REDDY's presentation at JPM which was reported here to show an estimated income off Generic Vascepa of close to 800 m$!
Income that could never be made from a niche indication with a 2 week limitation as the sales of VASCEPA up to 2018 demonstrates.
I can tell you are frustrated and tired of another "IGNORE yet at this point we can need any bit of help and your insights are the most profound in my overview of all the various opinions voiced here over time.
Still you might consider reaching out to the research staff of the legal teams representing AMARIN.
IT might just do the trick!